NO940523L - New pyrazine derivatives - Google Patents

New pyrazine derivatives

Info

Publication number
NO940523L
NO940523L NO940523A NO940523A NO940523L NO 940523 L NO940523 L NO 940523L NO 940523 A NO940523 A NO 940523A NO 940523 A NO940523 A NO 940523A NO 940523 L NO940523 L NO 940523L
Authority
NO
Norway
Prior art keywords
pyrazine derivatives
new pyrazine
new
compounds
derivatives
Prior art date
Application number
NO940523A
Other languages
Norwegian (no)
Other versions
NO301542B1 (en
NO940523D0 (en
Inventor
Herbert Koppe
Georg Speck
Klaus Stockhaus
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4127026A external-priority patent/DE4127026A1/en
Priority claimed from DE19914130461 external-priority patent/DE4130461A1/en
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of NO940523L publication Critical patent/NO940523L/en
Publication of NO940523D0 publication Critical patent/NO940523D0/en
Publication of NO301542B1 publication Critical patent/NO301542B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Disclosed are new compounds of formula (I) (R<1> to R<6> being defined in the description) which can be prepared by conventional methods. The compounds are suitable for use as active ingredients in drugs.
NO940523A 1991-08-16 1994-02-15 New pyrazine derivatives NO301542B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4127026A DE4127026A1 (en) 1991-08-16 1991-08-16 New 3-amino-6-chloro:pyrazine 2-carboxamide derivs. - useful as hypotensive, mucolytic, diuretic and antitumoural drugs
DE19914130461 DE4130461A1 (en) 1991-09-13 1991-09-13 New 3-amino-5-substd. carboxamide chloro-pyrazine carbamide cpds.
PCT/EP1992/001738 WO1993004048A1 (en) 1991-08-16 1992-07-31 New pyrazine derivatives, their preparation and their use

Publications (3)

Publication Number Publication Date
NO940523L true NO940523L (en) 1994-02-15
NO940523D0 NO940523D0 (en) 1994-02-15
NO301542B1 NO301542B1 (en) 1997-11-10

Family

ID=25906394

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940523A NO301542B1 (en) 1991-08-16 1994-02-15 New pyrazine derivatives

Country Status (23)

Country Link
EP (1) EP0598770B1 (en)
JP (1) JPH06509798A (en)
AT (1) ATE159250T1 (en)
AU (1) AU669122B2 (en)
CA (1) CA2115755A1 (en)
CZ (1) CZ280760B6 (en)
DE (1) DE59208974D1 (en)
DK (1) DK0598770T3 (en)
ES (1) ES2108129T3 (en)
FI (1) FI940696A0 (en)
GR (1) GR3025742T3 (en)
HK (1) HK1003137A1 (en)
HU (1) HUT67661A (en)
IE (1) IE922592A1 (en)
IL (1) IL102814A0 (en)
MX (1) MX9204637A (en)
NO (1) NO301542B1 (en)
NZ (1) NZ243959A (en)
RU (1) RU2124008C1 (en)
SG (1) SG46307A1 (en)
SK (1) SK17594A3 (en)
TW (1) TW213903B (en)
WO (1) WO1993004048A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6645969B1 (en) 1991-05-10 2003-11-11 Aventis Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
IL109570A0 (en) * 1993-05-17 1994-08-26 Fujisawa Pharmaceutical Co Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
DE4325822A1 (en) * 1993-07-31 1995-02-02 Hoechst Ag Substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, and medicament containing them
US5852046A (en) * 1993-08-03 1998-12-22 Hoechst Aktiengesellschaft Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them
DE4337609A1 (en) * 1993-11-04 1995-05-11 Boehringer Ingelheim Kg Novel pyrazinecarboxamide derivatives, their preparation and their use in medicines
DE4412334A1 (en) * 1994-04-11 1995-10-19 Hoechst Ag Substituted N-heteroaroylguanidines, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them
US5760230A (en) * 1996-10-11 1998-06-02 Bayer Aktiengesellschaft 4, 4'-bridged bis-2, 4-diaminoquinazolines
US6420354B1 (en) * 1998-06-08 2002-07-16 Advanced Medicine, Inc. Sodium channel drugs and uses
US6706732B1 (en) 1999-06-03 2004-03-16 Takeda Chemical Industries, Ltd. Nasal preparation of guanidinoimino quinoline derivatives
US6479498B1 (en) 1999-06-04 2002-11-12 Theravance, Inc. Sodium channel drugs and uses
US6156758A (en) * 1999-09-08 2000-12-05 Isis Pharmaceuticals, Inc. Antibacterial quinazoline compounds
EA007272B1 (en) * 2002-03-13 2006-08-25 Янссен Фармацевтика Н. В. New inhibitors of histone deacetylase
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
AU2004270162B2 (en) 2003-08-28 2010-05-13 Nicox S.A. Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use
EP1833482A4 (en) 2005-01-03 2011-02-16 Myriad Genetics Inc Compounds and therapeutical use thereof
US8258145B2 (en) 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
CA2597460A1 (en) 2005-02-24 2006-08-31 Nitromed, Inc. Nitric oxide enhancing diuretic compounds, compositions and methods of use
DE102008061247A1 (en) * 2008-12-10 2010-06-24 Christian-Albrechts-Universität Zu Kiel Inhibitors of dimethylarginine dimethylaminohydrolase
WO2012031563A1 (en) * 2010-09-10 2012-03-15 杭州本生药业有限公司 Heterocyclic amino berbamine derivatives, preparation method and use thereof
CN110041291B (en) * 2018-01-15 2021-02-26 北京采瑞医药科技研究院有限公司 Macamide derivative and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE639386A (en) * 1962-10-30
US3527758A (en) * 1967-04-13 1970-09-08 Merck & Co Inc Process for the preparation of pyrazinoylguanidines from a pyrazinoic azide and a guanidine
US3539569A (en) * 1968-08-21 1970-11-10 Merck & Co Inc Preparation of pyrazinoylguanidines from pyrazinoylureas
NL7803906A (en) * 1978-04-12 1979-10-16 Noordvos Schroeven Bv METHOD, DEVICE AND PROPELLER FOR DISTRIBUTING A GAS, POWDER OR LIQUID MATERIAL IN A LIQUID.

Also Published As

Publication number Publication date
IE922592A1 (en) 1993-02-24
NO301542B1 (en) 1997-11-10
SK17594A3 (en) 1994-12-07
EP0598770A1 (en) 1994-06-01
WO1993004048A1 (en) 1993-03-04
HK1003137A1 (en) 1998-10-09
IL102814A0 (en) 1993-01-31
ES2108129T3 (en) 1997-12-16
JPH06509798A (en) 1994-11-02
SG46307A1 (en) 1998-02-20
TW213903B (en) 1993-10-01
EP0598770B1 (en) 1997-10-15
MX9204637A (en) 1993-02-01
FI940696A (en) 1994-02-15
RU94015265A (en) 1997-02-20
FI940696A0 (en) 1994-02-15
NZ243959A (en) 1995-07-26
CZ280760B6 (en) 1996-04-17
DE59208974D1 (en) 1997-11-20
NO940523D0 (en) 1994-02-15
CZ33794A3 (en) 1994-07-13
DK0598770T3 (en) 1997-12-15
HUT67661A (en) 1995-04-28
RU2124008C1 (en) 1998-12-27
AU2387092A (en) 1993-03-16
AU669122B2 (en) 1996-05-30
CA2115755A1 (en) 1993-03-04
HU9400430D0 (en) 1994-05-30
GR3025742T3 (en) 1998-03-31
ATE159250T1 (en) 1997-11-15

Similar Documents

Publication Publication Date Title
NO301542B1 (en) New pyrazine derivatives
IL109526A0 (en) Benzofuranyl- and thiophenyl-alkanecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
FI872864A0 (en) Process for the preparation of pharmaceutically active benzimidazole derivatives
AU538424B2 (en) Piperazino phenylindane
LV10949A (en) Substituted 4-Phenyl-4-piperidinecarboxamide Compound for Pharmaceutical Formulation
RU94038042A (en) Derivatives of hexahydroazepine, pharmaceutical composition based on thereof and antipsychotropic agent
DK0628042T3 (en) Serotoninergic ergoline derivatives
NZ220800A (en) Tetrahydrobenzothiazoles and pharmaceutical compositions
SE8903312D0 (en) NEW 2-CARBONYL SUBSTITUTED N, N&#39;-DI- (TRIMETHOXYBENZOL) PIPERAZINES, PROCESS FOR PREPARING THE SAME AND THERAPEUTICAL COMPOUNDS CONTAINING THEM
ES2106866T3 (en) NEW DERIVATIVES OF 2H-BENZO (B) PIRANO SUBSTITUTED IN POSITION 4 BY ARILO OR N-HETEROARILO, PROCEDURE FOR ITS PREPARATION AND USE, AS WELL AS PREPARATIONS CONTAINING THE COMPOUNDS.
NO177707C (en) Process for the preparation of derivatives of 2- (3-pyridyl) -2-tetrahydrotiopyranecarbothioamide-1-oxide (1R, 2R)
TH2131B (en) Preparation of benzimidazole derivatives and their mixtures.